FIVE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR FEMALE AND SMALL ANNULUS PATIENTS WITH EDWARDS TAVR
Owlet presented at the TD Cowen 8th Annual Future of the Consumer Conference 2024.
Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool
Nomi’s payment infrastructure shortens Tellus’ payment cycle from as much as 30-60 days to just one day.
Agreement strengthens Edwards’ strategy to advance structural heart innovation.
Turner Imaging announced a significant milestone as they celebrate the sale of their 300th SMART-C system to the Surgical Center of Greensboro.
Gov. Cox this week toured Teva Pharmaceuticals, Stryker, and ARUP Laboratories to see firsthand the life-changing technology and innovation taking place in Utah’s dynamic life sciences community. Following the facility tours, Cox held on-site town halls to engage with employees. He applauded the industry’s mission to improve and save lives and noted that the sector […]
SOUTH SAN FRANCISCO, Calif and SALT LAKE CITY, May 28, 2024 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq:LAB) today announced that it has purchased the LSAXT system from Carterra®, a leading provider of high-throughput large and small molecule screening and characterization solutions. This instrument will enable Standard BioTools™ to further validate its SomaScan® Platform by measuring the […]
Published open-access today in Nature Genetics, “High-resolution genome-wide mapping of chromosome-arm-scale truncations induced by CRISPR–Cas9 editing” identifies novel evidence of a proximity bias in CRISPR-Cas9 gene knockouts and a debiasing (correcting) algorithm.
First patient, first visit is planned for early June 2024
SERA PROGNOSTICS EXPECTED TO BE ADDED TO RUSSELL 2000 AND 3000 INDEXES
A new campus building will place the University of Utah at the forefront of medical device innovation.
Malawi Ministry of Health, bioMérieux, and Pfizer Form Country’s First Multisectoral Collaboration to Help Address Antimicrobial Resistance
New investment drives development of advanced AI tools for mental health care screening and monitoring
The UCLA research team created a low cost and customizable lipid nanoparticle using “click chemistry” for precise targeting of cancer cell surface markers
These three U.S. cities are putting themselves on the biotech map as unsung hubs of the industry.
Versatile analog device offers fast inflation and ease of use, streamlining patient care
PolarityTE Secures $22.5 Million Financing to Advance SkinTE Phase III Pivotal Study in Diabetic Foot Ulcers
Study to Evaluate SOR102, a Novel Oral Dual-Acting Antibody Targeting TNF⍺ and IL-23 (p19) for Inflammatory Bowel Disease
Major Milestone for EVŌQ Nano’s Biotech Arm Targeting Antibiotic-Resistant Bacterial Infections Linked to Cystic Fibrosis and Other Lung Diseases SALT LAKE CITY, Utah, (May 15, 2024) — EVŌQ Bio, a wholly-owned subsidiary of EVŌQ Nano, today announced the successful completion of a Pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) […]
Experienced healthcare veteran brings a broad background spanning clinical, regulatory, operations, marketing, and business leadership to Merit’s Board of Directors SOUTH JORDAN, Utah, May 16, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that its shareholders elected Silvia M. Perez, President of the Commercial Branding and […]
Major Milestone for EVŌQ Nano’s Biotech Arm Targeting Antibiotic-Resistant Bacterial Infections Linked to Cystic Fibrosis and Other Lung Diseases
Dr. Bearss will be the Chair of the “Drug Discovery for Neurodegenerative Diseases” session, on May 23.
Joe Wright Appointed President, Expands Deep Bench of Leadership Team Talent; Supports “Continued Growth Initiatives” Program.
New products broaden Merit’s leadership in embolotherapy.
Parents in the United Kingdom will soon have access to Owlet’s Dream Sock with UKCA certification.
Groundbreaking at-home pivotal trial of a much-anticipated therapeutic device is underway.
BioHive-2, an NVIDIA DGX SuperPOD with NVIDIA DGX H100 systems, ranked #35 in the TOP500 list of the most powerful supercomputers in the world across all industries as of May 2024.
BioHive Live, BioHive’s inaugural industry-wide event with over 350 registrants took center stage at the Hale Center Theatre in Sandy, Utah on Wednesday. The event featured a series of thought-provoking speakers who engaged, inspired and challenged the audience. Jared Bauer, CEO of Seek Labs and BioHive board chair, welcomed attendees along with Aimee Edwards, BioHive […]
NYON, Switzerland–(BUSINESS WIRE)– Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company’s breakthrough RESILIA tissue technology, designed to extend the valve’s durability.* Edwards’ SAPIEN 3 Ultra RESILIA valve recently received CE Mark† for use in patients with heart valve disease […]
SALT LAKE CITY, May 07, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the reorganization of its European operations to better align company resources to its domestic opportunities while continuing to serve key biopharma partners and patients outside the United States. As part of […]
Ultradent proudly announces the acquisition of Ease-In-Shields™ from ViewMax Solutions, LLC. Ease-In-Shields provides unique eye protection for laser and curing light users, with their double patented shape, allowing the shields to fit into most loupe and eyewear shapes for maximum safety. Of the Ease-in-Shield acquisition, Scot Andersen, Ultradent’s Vice-President of Business Development, said, “After years […]
